Literature DB >> 15781156

Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level.

Mitchell P Fink1, Russell L Delude.   

Abstract

The multiple organ dysfunction syndrome (MODS) is the most common cause of death among patients requiring care in an ICU. There is widespread agreement that MODS is the clinical manifestation of a dysregulated inflammatory response. This article, however, summarizes some tantalizing data to support the view that derangements in the formation or function of specialized structures in epithelial cells, tight junctions, may be a key factor leading to lung, liver, gut, and perhaps kidney dysfunction associated with such conditions as sepsis and acute lung injury syndrome that are caused by dysregulated inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781156     DOI: 10.1016/j.ccc.2005.01.005

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  95 in total

1.  Cecal ligation and puncture followed by methicillin-resistant Staphylococcus aureus pneumonia increases mortality in mice and blunts production of local and systemic cytokines.

Authors:  Enjae Jung; Erin E Perrone; Zhe Liang; Elise R Breed; Jessica A Dominguez; Andrew T Clark; Amy C Fox; W Michael Dunne; Eileen M Burd; Alton B Farris; Richard S Hotchkiss; Craig M Coopersmith
Journal:  Shock       Date:  2012-01       Impact factor: 3.454

2.  Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock.

Authors:  Yongqing Li; Hasan B Alam
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  Nutritional stimulation of the autonomic nervous system.

Authors:  Misha D P Luyer; Quirine Habes; Richard van Hak; Wim Buurman
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

4.  Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.

Authors:  Laura E Fredenburgh; Margarita M Suárez Velandia; Jun Ma; Torsten Olszak; Manuela Cernadas; Joshua A Englert; Su Wol Chung; Xiaoli Liu; Cynthia Begay; Robert F Padera; Richard S Blumberg; Stephen R Walsh; Rebecca M Baron; Mark A Perrella
Journal:  J Immunol       Date:  2011-10-03       Impact factor: 5.422

5.  Non-invasive markers of gut wall integrity in health and disease.

Authors:  Joep P M Derikx; Misha D P Luyer; Erik Heineman; Wim A Buurman
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

6.  Non-invasive assessment of barrier integrity and function of the human gut.

Authors:  Joep Grootjans; Geertje Thuijls; Froukje Verdam; Joep Pm Derikx; Kaatje Lenaerts; Wim A Buurman
Journal:  World J Gastrointest Surg       Date:  2010-03-27

7.  Intestinal epithelium is more susceptible to cytopathic injury and altered permeability than the lung epithelium in the context of acute sepsis.

Authors:  Mark W Julian; Shengying Bao; Daren L Knoell; Ruairi J Fahy; Guohong Shao; Elliott D Crouser
Journal:  Int J Exp Pathol       Date:  2011-08-13       Impact factor: 1.925

Review 8.  Can we protect the gut in critical illness? The role of growth factors and other novel approaches.

Authors:  Jessica A Dominguez; Craig M Coopersmith
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

Review 9.  A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis.

Authors:  Eleanor A Fallon; Bethany M Biron-Girard; Chun-Shiang Chung; Joanne Lomas-Neira; Daithi S Heffernan; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2018-02-02       Impact factor: 4.962

10.  Removal of inflammatory ascites is associated with dynamic modification of local and systemic inflammation along with prevention of acute lung injury: in vivo and in silico studies.

Authors:  Bryanna Emr; David Sadowsky; Nabil Azhar; Louis A Gatto; Gary An; Gary F Nieman; Yoram Vodovotz
Journal:  Shock       Date:  2014-04       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.